Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Depreciation & Amortization (CF): 2023-2025

Historic Depreciation & Amortization (CF) for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to $416,000.

  • Camp4 Therapeutics' Depreciation & Amortization (CF) fell 0.48% to $416,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 1.63%. This contributed to the annual value of $1.7 million for FY2024, which is 1.07% up from last year.
  • Camp4 Therapeutics' Depreciation & Amortization (CF) amounted to $416,000 in Q3 2025, which was down 3.26% from $430,000 recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' Depreciation & Amortization (CF) peaked at $436,000 during Q1 2024, and registered a low of $416,000 during Q3 2025.
  • For the 3-year period, Camp4 Therapeutics' Depreciation & Amortization (CF) averaged around $424,750, with its median value being $422,500 (2024).
  • In the last 5 years, Camp4 Therapeutics' Depreciation & Amortization (CF) dropped by 3.91% in 2024 and then increased by 1.42% in 2025.
  • Over the past 3 years, Camp4 Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $435,000 in 2023, then declined by 3.91% to $418,000 in 2024, then decreased by 0.48% to $416,000 in 2025.
  • Its last three reported values are $416,000 in Q3 2025, $430,000 for Q2 2025, and $421,000 during Q1 2025.